Evidence map›Paper›PMID 40114573›Full record

ArticleEndocrine, metabolic & immune disorders drug targets2026

Differences in Thyroid Autoimmunity and Thyroid Function Tests Between Individuals with and without Obesity: Is There a Correlation with Obesity Degree?

Seher Çetinkaya Altuntaş

Abstract read
In one paragraph

Article in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Seher Çetinkaya AltuntaşDivision of Endocrinology and Metabolism, Department of Internal Medicine Bursa Yuksek Ihtisas Education and Training Hospital, University of Health Sciences, Bursa, Turkey.ORCID 0000-0002-9733-9443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity, a rapidly escalating global health concern, is associated with comorbidities and chronic inflammation. However, the link between obesity and thyroid autoimmunity remains unclear.

objectiveThis case-control study, conducted at a tertiary care center, aimed to elucidate the relationship between obesity and the degree of obesity, thyroid autoimmunity, and TFTs in euthyroid individuals with a BMI >30 kg/m2 and explore variations based on the degree of obesity.

methodsFree thyroid hormones, TSH, thyroid peroxidase antibodies (anti-TPO), anti-thyroglobulin antibodies (Anti-Tg), and metabolic parameters (glucose, lipid profile, insulin resistance, hemoglobin A1c) were measured in 164 euthyroid patients with obesity and 73 lean subjects aged 18-65 years. Subjects with obesity were stratified into three groups based on body mass index (BMI): first-degree obesity (BMI 30-34.9 kg/m2), second-degree obesity (BMI 35-39.9 kg/m2), and third-degree obesity (BMI ≥ 40 kg/m2).

resultsThe prevalence of thyroid antibody positivity was significantly higher in the obese group compared with the non-obese group, specifically for anti-TPO (45 (27.4%) vs. 7 (9.6%) and anti- Tg (35 (21.3%) vs. 5 (6.8%). Anti-Tg titers were elevated in the obese group (p=0.006), but anti- TPO levels were similar across the groups. Among the BMI-stratified groups, individuals with first and second-degree obesity exhibited higher anti-TPO positivity and anti-Tg titers compared with the control group. No significant differences were found in the third-degree obesity group. TSH and fT4 levels were higher in the obese group compared with the non-obese group (p=0.016 and p=0.045, respectively), whereas fT3 levels and the fT3/fT4 ratio remained consistent across the groups. Although no direct correlation was found between thyroid autoantibodies and metabolic parameters, individuals positive for anti-TPO and/or anti-Tg exhibited worse metabolic profiles compared with individuals who were antibody-negative.

conclusionThere is an increase in thyroid autoimmunity among euthyroid individuals with obesity; however, this increase does not appear to be proportional to BMI. The effect of antibody presence on metabolic parameters in individuals with obesity is not yet fully understood.

Indexed as

AutoimmunityObesityThyroid GlandThyroiditis, AutoimmuneAdolescentAdultAgedAutoantibodiesBody Mass IndexCase-Control StudiesFemaleHumansMaleMiddle AgedThyroid Function TestsThyroid HormonesAutoantibodiesThyroid HormonesAnti-thyroglobulinhashimoto's thyroiditisinsulin resistanceobesitythyroid antibodiesthyroid peroxidase antibody

Identifiers

PMID40114573
PMCPMC13334243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.